Stock A314130 GENOME & COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Genome & Company

Equities

A314130

KR7314130006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
6,910 KRW +2.98% Intraday chart for Genome & Company -1.71% -44.68%
Jan. 24 Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio®? for the Treatment of Gastric Cancer Poster Presented at ASCO GI CI
2023 Genome & Company Announces Positive Results from Interim Analysis of Gen-001 Plus Avelumab (Bavencio®?) Phase II Trial CI

Chart calendar Genome & Company

8105a0c4.R16kzS_BSPgaCEnL6d4u5KRnQX3mq00sFUPpD1cyHT4.Nw39_GqAILRWbR35n5dBis4iHg2NwCt0dxylUDVdSlgEB-KMeqcJzColLg~7c501857d58274612bfb1529d5b02ffc

Upcoming events on Genome & Company

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-25 Q2 2024 Earnings Release (Projected)
2024-11-24 Q3 2024 Earnings Release (Projected)

Past events on Genome & Company

2024-01-25 08:00 pm Investor Meeting
2024-01-22 07:30 pm Investor Meeting - Day 2
2024-01-21 07:30 pm Investor Meeting - Day 1
2023-11-13 Q3 2023 Earnings Release
2023-08-20 09:30 pm Investor Meeting
2023-08-13 Q2 2023 Earnings Release
2023-05-18 03:00 am Investor Meeting
2023-05-14 Q1 2023 Earnings Release
2023-03-20 Q4 2022 Earnings Release
2022-11-27 Q3 2022 Earnings Release
2022-08-28 Interim 2022 Earnings Release
2022-05-29 Q1 2022 Earnings Release
2021-05-16 Q1 2021 Earnings Release
2021-03-18 FY 2020 Earnings Release

Upcoming sector events for Genome & Company

2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
2024-05-01 06:30 am UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
2024-05-01 06:30 am BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
2024-05-01 07:00 am ALKERMES PLC: Q1 2024 Earnings Release
2024-05-01 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
2024-05-01 CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Genome & Company

Today CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-29 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 04:01 pm MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-27 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. A314130 Stock
  4. Calendar Genome & Company